Evidence map›Paper›PMID 36687466›Full record

ArticleNeurobiology of pain (Cambridge, Mass.)

Betulinic acid analogs inhibit N- and T-type voltage-gated calcium channels to attenuate nerve-injury associated neuropathic and formalin models of pain.

Aida Calderon-Rivera, Kimberly Gomez, Santiago Loya-López, E M Kithsiri Wijeratne, Harrison Stratton, Cheng Tang, Paz Duran, Kyleigh Masterson, Omar Alsbiei, A A Leslie Gunatilaka and 1 more

Open access · goldAbstract read
In one paragraph

Article in Neurobiology of pain (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Ethanolic Extracts ofAdvances in pharmacological and pharmaceutical sciences · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Aida Calderon-RiveraDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, United States.
Kimberly GomezDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, United States.
Santiago Loya-LópezDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, United States.
E M Kithsiri WijeratneNatural Products Center, School of Natural Resources and the Environment, College of Agriculture and Life Sciences, The University of Arizona, Tucson, AZ, United States.
Harrison StrattonDepartment of Pharmacology, College of Medicine, The University of Arizona, Tucson, AZ, United States.
Cheng TangDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, United States.
Paz DuranDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, United States.
Kyleigh MastersonNYU Pain Research Center, New York University, New York, NY, United States.
Omar AlsbieiNYU Pain Research Center, New York University, New York, NY, United States.
A A Leslie GunatilakaNatural Products Center, School of Natural Resources and the Environment, College of Agriculture and Life Sciences, The University of Arizona, Tucson, AZ, United States.
Rajesh KhannaDepartment of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, United States.
New York University · USUniversity of Arizona · US

Funding

CRMP2, mitochondria, and Huntington’s diseaseR01NS098772 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI BRUSTOVETSKY, NICKOLAY, KHANNA, RAJESH · 2017 to 2021
$2.8M
Sentrin proteases, CRMP2 deSUMOylation, and Chronic PainR01NS120663 · NINDS · UNIVERSITY OF FLORIDA · PI KHANNA, RAJESH · 2020 to 2021
$2.6M
NINDS NIH HHS R01 NS098772NINDS NIH HHS R01 NS120663
6 · The paper itself

Abstract

Over the past three decades, there has been a significant growth in the use of natural products, with approximately 80% of individuals using them for some aspect of primary healthcare. Our laboratories have identified and studied natural compounds with analgesic effects from dry land plants or their associated fungus during the past ten years. Here, we isolated and characterized thirteen betulin analogs and fifteen betulinic acid analogs for their capacity to prevent calcium influx brought on by depolarization in sensory neurons. The in vitro inhibition of voltage-gated calcium channels by the top drugs was then assessed using whole cell patch clamp electrophysiology. In vivo experiments, conducted at two sites, evaluated the best compound in acute and tonic, neuropathic, inflammatory, post-operative and visceral models of pain. We found that the betulinic acid analog

Indexed as

AnalgesicBA, Betulinic acidBetulin analogsBetulinic acid analogsCaV2.2, N-type voltage-gated calcium channelCaV3, T-type voltage-gated calcium channelDRG, dorsal root gangliaFormalin modelHVA, high voltage-gatedLVA, low voltage-gatedPainSNI, spared nerve injurySpared nerve injury modeVGCCs, Voltage-gated calcium channelsVoltage-gated calcium channels

Identifiers

PMID36687466
PMCPMC9853350
OpenAlexW4316019932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.